ClinicalTrials.govpublic full text
Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma
recurrent lymphoma, recurrent malignant solid neoplasm, recurrent primary central nervous system neoplasm, refractory lymphoma, refractory malignant solid neoplasm, refractory primary central nervous system neoplasm, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 967423
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.